Illumina Inc (ILMN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 28 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Illumina Inc   (NASDAQ: ILMN)


Illumina Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Illumina Inc's ROI in the second quarter of 2026?
Illumina Inc achieved a return on average invested assets (ROI) of 19.61 % in its second quarter of 2026, this is above ILMN's average return on investment of 4.45%.
Illumina Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROI fell compared to the first quarter of 2026, despite the net income growth of 54.48% from the first quarter of 2026.

Within the Healthcare sector 55 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 80 to 278.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Investment Change TTM 7.96 % 5.03 % -16.16 % -30.93 % -37.08 %
Y / Y Net Income Change TTM -34.37 % - - - -
Investment (TTM) in Millions 5,072 4,166 4,213 3,375 3,750
Return On Investment (TTM) 19.61 % 22.01 % 22.37 % 18.91 % 32.26 %
ILMN's Overall Ranking # 278 # 80 # 235 # 337 # 32
Seq. Investment Change TTM 8.53 % 2.02 % 2.36 % -4.74 % 5.58 %
Seq. Net Income Change TTM -3.28 % 0.35 % 21.08 % -44.15 % -
Net Income (TTM) in Millions 825 853 850 702 1,257

ILMN Company Profile >> Back to ILMN Roi Comparisons >> See Annual ILMN Return On Investment



Return On Investment ILMN's Ranking
Within: No.
Industry # 3
Sector # 56
Overall # 278

Return On Investment Statistics
High Average Low
32.26 %
4.45 %
-53.1 %
(Jun 29 2025)   (Jul 02 2023)



  News about Illumina Inc Return on Investment ROI

Illumina Inc Appoints New Leadership and Reaffirms Financial Outlook

April 9, 2024

Illumina Appoints New CFO and CSO, Reaffirms Financial Guidance
San Diego-based biotechnology company, Illumina Inc (NASDAQ: ILMN), recently made significant changes to its leadership team. Ankur Dhingra has been appointed as the Chief Financial Officer (CFO), while Jakob Wedel will take on the role of Chief Strategy and Corporate Development Officer (CSO). Additionally, Joydeep Goswami, the former CFO, will continue to serve as an advisor until June 30th.
With the new appointments, Illumina aims to strengthen its financial and strategic expertise in order to drive growth and innovation in the DNA sequencing and array-based technologies industry. Dhingra brings a wealth of experience to the company, having previously served as the CFO of several successful biotech companies. Wedel, on the other hand, has a strong background in strategic planning and corporate development, making him a valuable addition to Illumina s leadership team.





Financial Statements
Illumina Inc's II. Quarter Investments $ 5,072 Millions ILMN's Balance sheet
Illumina Inc's II. Quarter Income $ 207 Millions Quarterly ILMN's Income Statement
ILMN's Income by Division See ILMN's Income by Division


ILMN Annual Return On Investment (Dec 28 2025)
2025		 (Dec 29 2024)
2024		 (Dec 31 2023)
2023		 (Jan 01 2023)
2022		 (Jan 02 2022)
2021
Total Investments in Millions 4,213 3,863 7,234 8,086 14,124
Y / Y Investment Growth 9.06 % -46.6 % -10.54 % -42.75 % 122.74 %
Net Income in Millions 850 -1,223 -1,161 -4,404 762
Y / Y Net Income Growth - - - - 16.16 %
Annual Return On Investment 20.18 % -31.66 % -16.05 % -54.46 % 5.4 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 20.18 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ILMN's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ILMN's Competitors
Subscribers only: Roi for Illumina Inc's Suppliers
Subscribers only: Return On Investment for ILMN's Customers

Other Ratios
ILMN's Roa ILMN's Inventory Turnover Ratio ILMN's Growth Rates ILMN's Dividend Statistics
ILMN's Profitability Ratios ILMN's Asset Turnover Ratio ILMN's Dividend Growth
ILMN's Roe ILMN's Valuation Ratios ILMN's Financial Strength Ratios ILMN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 28 2026, within Healthcare Sector ROI
Elite Pharmaceuticals Inc   53.48 %
Idexx Laboratories Inc  51.80 %
Aurinia Pharmaceuticals Inc   50.35 %
Qhslab Inc   48.94 %
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %

Date modified: 2026-09-26T07:13:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.